272 related articles for article (PubMed ID: 32363840)
1. Effects of Antiretroviral Therapy on CD4+ Cell Count, HIV Viral Load and Death in a South African Cohort: A Modelling Study.
Shoko C; Chikobvu D; Bessong PO
Pak J Biol Sci; 2020 Mar; 23(4):542-551. PubMed ID: 32363840
[TBL] [Abstract][Full Text] [Related]
2. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
Shoko C; Chikobvu D; Bessong PO
S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements.
; Lanoy E; May M; Mocroft A; Phillip A; Justice A; Chêne G; Furrer H; Sterling T; Monforte AD; Force L; Gill J; Harris R; Hogg RS; Rockstroh J; Saag M; Khaykin P; de Wolf F; Sterne JA; Costagliola D
AIDS; 2009 Oct; 23(16):2199-208. PubMed ID: 19779320
[TBL] [Abstract][Full Text] [Related]
4. Modelling immune deterioration, immune recovery and state-specific duration of HIV-infected women with viral load adjustment: using parametric multistate model.
Dessie ZG; Zewotir T; Mwambi H; North D
BMC Public Health; 2020 Mar; 20(1):416. PubMed ID: 32228523
[TBL] [Abstract][Full Text] [Related]
5. Decline in CD4 T lymphocytes with monotherapy bridging strategy for non-adherent adolescents living with HIV infection: Results of the IMPAACT P1094 randomized trial.
Agwu AL; Warshaw MG; McFarland EJ; Siberry GK; Melvin AJ; Wiznia AA; Fairlie L; Boyd S; Harding P; Spiegel HML; Abrams EJ; Carey VJ;
PLoS One; 2017; 12(6):e0178075. PubMed ID: 28604824
[TBL] [Abstract][Full Text] [Related]
6. A superiority of viral load over CD4 cell count when predicting mortality in HIV patients on therapy.
Shoko C; Chikobvu D
BMC Infect Dis; 2019 Feb; 19(1):169. PubMed ID: 30770728
[TBL] [Abstract][Full Text] [Related]
7. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
[TBL] [Abstract][Full Text] [Related]
8. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
Panel de expertos de GESIDA y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
[TBL] [Abstract][Full Text] [Related]
9. CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE.
; Young J; Psichogiou M; Meyer L; Ayayi S; Grabar S; Raffi F; Reiss P; Gazzard B; Sharland M; Gutierrez F; Obel N; Kirk O; Miro JM; Furrer H; Castagna A; De Wit S; Muñoz J; Kjaer J; Grarup J; Chêne G; Bucher H
PLoS Med; 2012; 9(3):e1001194. PubMed ID: 22448150
[TBL] [Abstract][Full Text] [Related]
10. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.
Hogg RS; Yip B; Chan KJ; Wood E; Craib KJ; O'Shaughnessy MV; Montaner JS
JAMA; 2001 Nov; 286(20):2568-77. PubMed ID: 11722271
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral therapy improves survival among TB-HIV co-infected patients who have CD4+ T-cell count above 350cells/mm
Mutembo S; Mutanga JN; Musokotwane K; Alisheke L; Whalen CC
BMC Infect Dis; 2016 Oct; 16(1):572. PubMed ID: 27751168
[TBL] [Abstract][Full Text] [Related]
12. The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis.
Murray M; Hogg RS; Lima VD; May MT; Moore DM; Abgrall S; Bruyand M; D'Arminio Monforte A; Tural C; Gill MJ; Harris RJ; Reiss P; Justice A; Kirk O; Saag M; Smith CJ; Weber R; Rockstroh J; Khaykin P; Sterne JA;
HIV Med; 2012 Feb; 13(2):89-97. PubMed ID: 21819529
[TBL] [Abstract][Full Text] [Related]
13. Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition.
Cingolani A; Cozzi Lepri A; Castagna A; Goletti D; De Luca A; Scarpellini P; Fanti I; Antinori A; d'Arminio Monforte A; Girardi E
Clin Infect Dis; 2012 Mar; 54(6):853-61. PubMed ID: 22157323
[TBL] [Abstract][Full Text] [Related]
14. Time-homogeneous Markov process for HIV/AIDS progression under a combination treatment therapy: cohort study, South Africa.
Shoko C; Chikobvu D
Theor Biol Med Model; 2018 Jan; 15(1):3. PubMed ID: 29343268
[TBL] [Abstract][Full Text] [Related]
15. HIV disease progression in the first year after delivery among African women followed in the HPTN 046 clinical trial.
Watts DH; Brown ER; Maldonado Y; Herron C; Chipato T; Reddy L; Moodley D; Nakabiito C; Manji K; Fawzi W; George K; Richardson P; Zwerski S; Coovadia H; Fowler M;
J Acquir Immune Defic Syndr; 2013 Nov; 64(3):299-306. PubMed ID: 23846568
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival in HIV positive patients with up to 15 Years of antiretroviral therapy.
McManus H; O'Connor CC; Boyd M; Broom J; Russell D; Watson K; Roth N; Read PJ; Petoumenos K; Law MG;
PLoS One; 2012; 7(11):e48839. PubMed ID: 23144991
[TBL] [Abstract][Full Text] [Related]
17. Markov modelling of viral load adjusting for CD4 orthogonal variable and multivariate conditional autoregressive mapping of the HIV immunological outcomes among ART patients in Zimbabwe.
Matsena Zingoni Z; Chirwa TF; Todd J; Musenge E
Theor Biol Med Model; 2021 Aug; 18(1):16. PubMed ID: 34419087
[TBL] [Abstract][Full Text] [Related]
18. Modelling of viral load dynamics and CD4 cell count progression in an antiretroviral naive cohort: using a joint linear mixed and multistate Markov model.
Dessie ZG; Zewotir T; Mwambi H; North D
BMC Infect Dis; 2020 Mar; 20(1):246. PubMed ID: 32216755
[TBL] [Abstract][Full Text] [Related]
19. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study.
Guiguet M; Boué F; Cadranel J; Lang JM; Rosenthal E; Costagliola D;
Lancet Oncol; 2009 Dec; 10(12):1152-9. PubMed ID: 19818686
[TBL] [Abstract][Full Text] [Related]
20. Poor CD4 recovery and risk of subsequent progression to AIDS or death despite viral suppression in a South African cohort.
Takuva S; Maskew M; Brennan AT; Long L; Sanne I; Fox MP
J Int AIDS Soc; 2014; 17(1):18651. PubMed ID: 24594114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
